medroxyprogesterone acetate has been researched along with Cancer of the Thyroid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kurebayashi, J; Moriya, T; Otsuki, T; Sonoo, H; Tanaka, K; Yamamoto, Y | 1 |
1 other study(ies) available for medroxyprogesterone acetate and Cancer of the Thyroid
Article | Year |
---|---|
Medroxyprogesterone acetate decreases secretion of interleukin-6 and parathyroid hormone-related protein in a new anaplastic thyroid cancer cell line, KTC-2.
Topics: Carcinoma, Papillary; Cell Line, Tumor; Dexamethasone; Dihydrotestosterone; DNA Primers; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-6; Medroxyprogesterone Acetate; Microscopy, Phase-Contrast; Parathyroid Hormone-Related Protein; Progesterone; Receptors, Androgen; Receptors, Glucocorticoid; Receptors, Progesterone; RNA, Messenger; Secretory Rate; Thyroglobulin; Thyroid Neoplasms | 2003 |